UnitedHealth Group Incorporated $UNH Shares Sold by OMERS ADMINISTRATION Corp

Posted by Stanley Muller on Jul 26th, 2026

OMERS ADMINISTRATION Corp reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 53.0% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 278,321 shares of the healthcare conglomerate’s stock after selling 313,541 shares during the quarter. OMERS ADMINISTRATION Corp’s holdings in UnitedHealth Group were worth $75,311,000 as of its most recent filing with the SEC.

Other institutional investors have also recently added to or reduced their stakes in the company. Lombard Odier Asset Management Switzerland SA raised its holdings in shares of UnitedHealth Group by 5.8% during the first quarter. Lombard Odier Asset Management Switzerland SA now owns 48,003 shares of the healthcare conglomerate’s stock worth $12,989,000 after acquiring an additional 2,615 shares during the period. Mustico Financial Group Inc. boosted its stake in shares of UnitedHealth Group by 117.0% during the 1st quarter. Mustico Financial Group Inc. now owns 1,621 shares of the healthcare conglomerate’s stock worth $439,000 after acquiring an additional 874 shares during the period. Waverly Advisors LLC boosted its holdings in shares of UnitedHealth Group by 8.1% during the first quarter. Waverly Advisors LLC now owns 31,582 shares of the healthcare conglomerate’s stock worth $8,546,000 after acquiring an additional 2,370 shares during the period. Asset Management Group Inc. grew its stake in shares of UnitedHealth Group by 11.3% in the first quarter. Asset Management Group Inc. now owns 1,192 shares of the healthcare conglomerate’s stock valued at $322,000 after acquiring an additional 121 shares in the last quarter. Finally, Van Den Berg Management I Inc. raised its holdings in UnitedHealth Group by 10.6% in the 1st quarter. Van Den Berg Management I Inc. now owns 28,888 shares of the healthcare conglomerate’s stock valued at $7,817,000 after acquiring an additional 2,765 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Price Performance

UNH opened at $420.40 on Friday. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $461.62. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.80 and a current ratio of 0.78. The stock’s 50 day moving average price is $408.00 and its 200-day moving average price is $345.60. The stock has a market capitalization of $381.78 billion, a PE ratio of 27.05, a price-to-earnings-growth ratio of 1.46 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.94 by $1.44. The company had revenue of $112.03 billion during the quarter, compared to analyst estimates of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. UnitedHealth Group’s quarterly revenue was up .4% compared to the same quarter last year. During the same period last year, the business earned $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 19.69 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 23rd. Shareholders of record on Monday, June 15th were given a $2.32 dividend. The ex-dividend date was Monday, June 15th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.21. This represents a $9.28 annualized dividend and a yield of 2.2%. UnitedHealth Group’s payout ratio is 59.72%.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of research reports. Bank of America reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Monday, July 20th. JPMorgan Chase & Co. boosted their target price on shares of UnitedHealth Group from $466.00 to $516.00 and gave the company an “overweight” rating in a report on Tuesday, July 21st. UBS Group increased their target price on shares of UnitedHealth Group from $460.00 to $490.00 and gave the stock a “buy” rating in a research note on Friday, July 17th. Sanford C. Bernstein reiterated an “outperform” rating on shares of UnitedHealth Group in a report on Tuesday. Finally, Cantor Fitzgerald restated an “overweight” rating on shares of UnitedHealth Group in a report on Thursday, June 11th. Two analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $455.92.

Check Out Our Latest Stock Analysis on UNH

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

Positive Sentiment: UnitedHealth’s latest quarter beat profit estimates and management raised full-year earnings guidance, reinforcing confidence that the business is recovering after earlier pressure. UnitedHealth’s earnings comeback hides risk Wall Street can’t price
Positive Sentiment: JPMorgan reportedly increased its price target on UNH to $516, suggesting analysts see further upside following the improved earnings outlook. JPMorgan Chase & Co. Increases UnitedHealth Group (NYSE:UNH) Price Target to $516.00
Positive Sentiment: UNH has also been highlighted in multiple stock-screening and momentum pieces as a “buy” or strong momentum name, which can add to near-term trading interest. Is Trending Stock UnitedHealth Group Incorporated (UNH) a Buy Now?
Neutral Sentiment: UnitedHealth is being widely watched by retail and institutional investors after the strong quarter, but some of the recent articles are primarily commentary rather than new company-specific developments. Is Trending Stock UnitedHealth Group Incorporated (UNH) a Buy Now?
Negative Sentiment: Even with the upbeat earnings update, investors are still focused on risk factors such as medical cost inflation and margin pressure across the managed-care sector, which could limit how far the rally extends. Can Humana Beat Q2 Earnings Estimates on Growing Premiums?

About UnitedHealth Group

(Free Report)

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.